• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6厘米直径是肾上腺肿瘤行腹腔镜肾上腺切除术的上限吗?

Is 6 cm Diameter an Upper Limit for Adrenal Tumors to Perform Laparoscopic Adrenalectomy?

作者信息

Cicek Mehmet Cagatay, Gunseren Kadir Omur, Senol Kazım, Vuruskan Hakan, Yavascaoglu Ismet

机构信息

Department of Urology, Faculty of Medicine, Uludag University, Bursa, Turkey.

Department of General Surgery, Faculty of Medicine, Uludag University, Bursa, Turkey.

出版信息

J Laparoendosc Adv Surg Tech A. 2021 Mar;31(3):301-305. doi: 10.1089/lap.2020.0505. Epub 2020 Jul 21.

DOI:10.1089/lap.2020.0505
PMID:32716248
Abstract

We aimed to compare the results of patients who underwent laparoscopic adrenalectomy (LA) for masses ≥6 cm versus <6 cm in diameter in our tertiary referral university hospital. Three hundred thirty consecutive patients were divided into two groups according to tumor size (≥6 and <6 cm in diameter). Demographic variables, body mass index (BMI), lesion localization (right/left), tumor diameter, pathological diagnosis and surgical outcomes, including operation time, estimated blood loss (EBL), conversion to open surgery, complications, and length of hospital stay were compared between groups. Between February 2008 and March 2020, 53 patients (29 male-24 female) with ≥6 cm (L group) adrenal tumor and 277 patients (105 male-172 female) with <6 cm tumor (S group) underwent transperitoneal LA. One hundred sixty-eight (50.9%) tumors localized on the left side. In L group mean tumor size in female and male patients was 87.5 ± 40.8 mm (range 50-225 mm) and 67.3 ± 18.4 mm (range 10-100 mm), respectively ( < .05). Age, American Society of Anesthesiology scores, BMI, and mean operation time were similar between groups ( > .05). Postoperative complications were more often in L group ( = .005). EBL in group L and group S was 86 ± 70.4 mL (range 10-500 mL) and 55 ± 44.2 mL (range 10-300 mL), respectively ( = .003). Length of hospital stay in group L and group S was 3.7 ± 3.5 days (range 1-26) and 3 ± 1.6 days (range 1-9), respectively ( = .086). Significant variables in multivariate analysis, including gender (male), EBL, and postoperative complication rate, were entered into multivariate regression analysis, which presented that EBL and postoperative complication rates were independent significants for the L group. Six centimeters should not be considered as an upper limit of transperitoneal lateral LA and may be safely performed in centers with experience. Further studies are needed to confirm our data.

摘要

我们旨在比较在我们的三级转诊大学医院中,接受腹腔镜肾上腺切除术(LA)治疗直径≥6 cm与<6 cm肿块的患者的结果。330例连续患者根据肿瘤大小(直径≥6 cm和<6 cm)分为两组。比较两组之间的人口统计学变量、体重指数(BMI)、病变定位(右侧/左侧)、肿瘤直径、病理诊断和手术结果,包括手术时间、估计失血量(EBL)、转为开放手术、并发症和住院时间。在2008年2月至2020年3月期间,53例(29例男性 - 24例女性)肾上腺肿瘤直径≥6 cm(L组)和277例(105例男性 - 172例女性)肿瘤直径<6 cm(S组)的患者接受了经腹LA。168例(50.9%)肿瘤位于左侧。在L组中,女性和男性患者的平均肿瘤大小分别为87.5±40.8 mm(范围50 - 225 mm)和67.3±18.4 mm(范围10 - 100 mm)(<0.05)。两组之间的年龄、美国麻醉医师协会评分、BMI和平均手术时间相似(>0.05)。L组术后并发症更多见(=0.005)。L组和S组的EBL分别为86±70.4 mL(范围10 - 500 mL)和55±44.2 mL(范围10 - 300 mL)(=0.003)。L组和S组的住院时间分别为3.7±3.5天(范围1 - 26天)和3±1.6天(范围1 - 9天)(=0.086)。多因素分析中的显著变量,包括性别(男性)、EBL和术后并发症发生率,被纳入多因素回归分析,结果显示EBL和术后并发症发生率是L组的独立显著因素。6厘米不应被视为经腹侧方LA的上限,在有经验的中心可以安全地进行。需要进一步研究来证实我们的数据。

相似文献

1
Is 6 cm Diameter an Upper Limit for Adrenal Tumors to Perform Laparoscopic Adrenalectomy?6厘米直径是肾上腺肿瘤行腹腔镜肾上腺切除术的上限吗?
J Laparoendosc Adv Surg Tech A. 2021 Mar;31(3):301-305. doi: 10.1089/lap.2020.0505. Epub 2020 Jul 21.
2
Challenging risk factors for right and left laparoscopic adrenalectomy: A single centre experience with 272 cases.腹腔镜肾上腺切除术左右侧挑战性风险因素:单中心 272 例经验。
Int Braz J Urol. 2019 Jul-Aug;45(4):747-753. doi: 10.1590/S1677-5538.IBJU.2019.0131.
3
Robotic Adrenalectomy: Are We Expanding the Indications of Minimally Invasive Surgery?机器人肾上腺切除术:我们是否正在扩大微创手术的适应症?
J Laparoendosc Adv Surg Tech A. 2019 Jan;29(1):19-23. doi: 10.1089/lap.2018.0286. Epub 2018 Sep 28.
4
Lateral retroperitoneoscopic adrenalectomy for complicated adrenal tumor larger than 5 centimeters.经后腹腔镜肾上腺切除术治疗直径大于5厘米的复杂肾上腺肿瘤
Afr Health Sci. 2017 Mar;17(1):293-300. doi: 10.4314/ahs.v17i1.36.
5
Are Adrenal Lesions of 6 cm or More in Diameter a Contraindication to Laparoscopic Adrenalectomy? A Case-Control Study.直径大于或等于 6 厘米的肾上腺病变是否是腹腔镜肾上腺切除术的禁忌证?一项病例对照研究。
World J Surg. 2020 Mar;44(3):810-818. doi: 10.1007/s00268-019-05287-2.
6
Comparison of synchronous bilateral transperitoneal and posterior retroperitoneal laparoscopic adrenalectomy: results of a multicenter study.同期双侧经腹腔与后腹腔腹腔镜肾上腺切除术的比较:一项多中心研究的结果。
Surg Endosc. 2021 Mar;35(3):1101-1107. doi: 10.1007/s00464-020-07474-y. Epub 2020 Mar 9.
7
Robot-assisted posterior retroperitoneoscopic adrenalectomy using single-port access: technical feasibility and preliminary results.机器人辅助后腹腔镜单孔入路肾上腺切除术:技术可行性及初步结果。
Ann Surg Oncol. 2013 Aug;20(8):2741-5. doi: 10.1245/s10434-013-2891-z. Epub 2013 Mar 14.
8
Robot-assisted laparoscopic adrenalectomy: step-by-step technique and comparative outcomes.机器人辅助腹腔镜肾上腺切除术:分步技术和对比结果。
Eur Urol. 2014 Nov;66(5):898-905. doi: 10.1016/j.eururo.2014.04.003. Epub 2014 May 13.
9
Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients.影响肾上腺切除术手术入路、中转和发病率的风险因素:单机构 402 例系列研究。
Surg Endosc. 2013 Jul;27(7):2342-50. doi: 10.1007/s00464-013-2789-7. Epub 2013 Feb 13.
10
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients.腹腔镜手术方法在大肾上腺肿瘤切除中的适用性:一项针对200例患者的回顾性队列研究。
Surg Endosc. 2016 Aug;30(8):3532-40. doi: 10.1007/s00464-015-4643-6. Epub 2015 Nov 5.

引用本文的文献

1
Tailored surgery for large adrenal tumors: the minimally invasive to open (hybrid) approach.大型肾上腺肿瘤的个体化手术:从微创到开放(混合)入路
Updates Surg. 2025 Aug 29. doi: 10.1007/s13304-025-02388-7.
2
The Role of Minimally Invasive Adrenalectomy for Large Adrenal Tumors (≥6 cm): Evidence from a 10-Year Retrospective Study.微创肾上腺切除术对大肾上腺肿瘤(≥6厘米)的作用:一项10年回顾性研究的证据
J Clin Med. 2025 Jul 22;14(15):5176. doi: 10.3390/jcm14155176.
3
GBDKVA score: a scoring system for preoperative risk assessment of adrenal tumors ≤6cm.
GBDKVA评分:一种用于≤6cm肾上腺肿瘤术前风险评估的评分系统。
Front Endocrinol (Lausanne). 2025 Mar 17;16:1418535. doi: 10.3389/fendo.2025.1418535. eCollection 2025.
4
Feasibility of laparoscopic adrenalectomy in adrenal masses greater than 5 centimeters: a systematic review and meta-analysis.腹腔镜肾上腺切除术治疗直径大于5厘米肾上腺肿块的可行性:一项系统评价和荟萃分析。
Gland Surg. 2024 Jun 30;13(6):952-968. doi: 10.21037/gs-24-69. Epub 2024 Jun 27.
5
Side-specific factors for intraoperative hemodynamic instability in laparoscopic adrenalectomy for pheochromocytoma: a comparative study.腹腔镜嗜铬细胞瘤切除术术中血流动力学不稳定的侧别相关因素:一项对比研究。
Surg Endosc. 2024 Aug;38(8):4571-4582. doi: 10.1007/s00464-024-10974-w. Epub 2024 Jul 1.
6
Laparoscopic transperitoneal adrenalectomy for adrenal tumours of 6 cm or greater: A single-centre experience.腹腔镜经腹肾上腺切除术治疗直径6厘米及以上肾上腺肿瘤:单中心经验
J Minim Access Surg. 2024 Jan 1;20(1):47-54. doi: 10.4103/jmas.jmas_217_22. Epub 2023 Apr 13.
7
Should We Hesitate to Perform Laparoscopic Adrenalectomy for Pheochromacytomas Larger Than 5 cm in Diameter with No Pre-Operative Suspicious Criteria for Malignancy?对于直径大于5厘米且术前无恶性可疑标准的嗜铬细胞瘤,我们是否应犹豫是否进行腹腔镜肾上腺切除术?
Sisli Etfal Hastan Tip Bul. 2022 Jun 28;56(2):244-249. doi: 10.14744/SEMB.2021.81598. eCollection 2022.
8
Tumour size in adrenal tumours: its importance in the indication of adrenalectomy and in surgical outcomes-a single-centre experience.肾上腺肿瘤的肿瘤大小:在肾上腺切除术适应证和手术结果中的重要性——单中心经验。
J Endocrinol Invest. 2022 Oct;45(10):1999-2006. doi: 10.1007/s40618-022-01836-0. Epub 2022 Jun 24.
9
Outcomes after Surgical Treatment of Metastatic Disease in the Adrenal Gland; Valuable for the Patient?肾上腺转移性疾病手术治疗后的结果;对患者有价值吗?
Cancers (Basel). 2021 Dec 29;14(1):156. doi: 10.3390/cancers14010156.